Designed to detect IgG, IgA and IgM Heparin-Associated Antibodies
It is now known that antibodies associated with Type II HIT recognize sites on “platelet factor 4” (PF4) that are created when PF4 is complexed with heparin or another linear polyanionic compound such as polyvinyl sulfonate (PVS).
Gen-Probe’s PF4 Enhanced® Solid Phase ELISA is a patented technology (US Patent# 5,972,718) for the detection of PF4 heparin-dependent antibodies. A formulation change to the Stopping Solution has been identified for LIFECODES’ ELISA-based assays. The new solution will eliminate hazards that are associated with the current reagent, as well as eliminate special chemical disposal needs. Read More >>
- Fast - assay can be completed in 2 hours
- Cost effective
- Consistent ELISA reliability
- Up to 45 samples in duplicate
| Catalog No. | Description | Size | Avg Shelf Life | Storage |
|---|---|---|---|---|
| X-HAT13 | PF4 Enhanced® | Maximum 13 Tests/Kit | 2 years | 2–8°C |
| X-HAT45 | PF4 Enhanced® | Maximum 45 Tests/Kit | 2 years | 2–8°C |
For In Vitro Diagnostic Use.
Learn more about how to improve the clinical significance of a positive PF4-heparin ELISA result.